Carta científica
Bradicardia extrema secundaria al uso de galantamina
Extreme bradycardia associated with galantamine
Leído
8681
Vecesse ha leído el artículo
1054
Total PDF
7627
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 26 | 7 | 33 |
| 2025 11 | 79 | 14 | 93 |
| 2025 10 | 54 | 14 | 68 |
| 2025 9 | 69 | 9 | 78 |
| 2025 8 | 74 | 12 | 86 |
| 2025 7 | 61 | 12 | 73 |
| 2025 6 | 53 | 3 | 56 |
| 2025 5 | 75 | 5 | 80 |
| 2025 4 | 49 | 5 | 54 |
| 2025 3 | 75 | 5 | 80 |
| 2025 2 | 74 | 5 | 79 |
| 2025 1 | 63 | 3 | 66 |
| 2024 12 | 58 | 9 | 67 |
| 2024 11 | 67 | 2 | 69 |
| 2024 10 | 78 | 6 | 84 |
| 2024 9 | 92 | 3 | 95 |
| 2024 8 | 91 | 5 | 96 |
| 2024 7 | 67 | 3 | 70 |
| 2024 6 | 54 | 3 | 57 |
| 2024 5 | 71 | 6 | 77 |
| 2024 4 | 85 | 6 | 91 |
| 2024 3 | 88 | 5 | 93 |
| 2024 2 | 92 | 19 | 111 |
| 2024 1 | 78 | 5 | 83 |
| 2023 12 | 108 | 9 | 117 |
| 2023 11 | 131 | 17 | 148 |
| 2023 10 | 132 | 7 | 139 |
| 2023 9 | 96 | 4 | 100 |
| 2023 8 | 78 | 8 | 86 |
| 2023 7 | 150 | 6 | 156 |
| 2023 6 | 168 | 4 | 172 |
| 2023 5 | 169 | 8 | 177 |
| 2023 4 | 131 | 3 | 134 |
| 2023 3 | 100 | 10 | 110 |
| 2023 2 | 55 | 5 | 60 |
| 2022 1 | 75 | 3 | 78 |
| 2022 12 | 54 | 6 | 60 |
| 2022 11 | 74 | 5 | 79 |
| 2022 10 | 57 | 11 | 68 |
| 2022 9 | 61 | 4 | 65 |
| 2022 8 | 70 | 9 | 79 |
| 2022 7 | 59 | 13 | 72 |
| 2022 6 | 46 | 10 | 56 |
| 2022 5 | 61 | 6 | 67 |
| 2022 4 | 66 | 16 | 82 |
| 2022 3 | 88 | 8 | 96 |
| 2022 2 | 82 | 4 | 86 |
| 2021 1 | 97 | 10 | 107 |
| 2021 12 | 56 | 6 | 62 |
| 2021 11 | 48 | 8 | 56 |
| 2021 10 | 78 | 16 | 94 |
| 2021 9 | 56 | 13 | 69 |
| 2021 8 | 48 | 4 | 52 |
| 2021 7 | 30 | 6 | 36 |
| 2021 6 | 38 | 10 | 48 |
| 2021 5 | 46 | 3 | 49 |
| 2021 4 | 72 | 30 | 102 |
| 2021 3 | 225 | 9 | 234 |
| 2021 2 | 33 | 7 | 40 |
| 2020 1 | 33 | 14 | 47 |
| 2020 12 | 27 | 7 | 34 |
| 2020 11 | 27 | 9 | 36 |
| 2020 10 | 24 | 7 | 31 |
| 2020 9 | 22 | 9 | 31 |
| 2020 8 | 33 | 12 | 45 |
| 2020 7 | 28 | 11 | 39 |
| 2020 6 | 18 | 8 | 26 |
| 2020 5 | 14 | 7 | 21 |
| 2020 4 | 5 | 3 | 8 |
| 2020 3 | 2 | 2 | 4 |
| 2018 5 | 4 | 3 | 7 |
| 2018 4 | 12 | 5 | 17 |
| 2018 3 | 26 | 1 | 27 |
| 2018 2 | 13 | 2 | 15 |
| 2018 1 | 27 | 8 | 35 |
| 2017 12 | 21 | 3 | 24 |
| 2017 11 | 12 | 3 | 15 |
| 2017 10 | 17 | 5 | 22 |
| 2017 9 | 18 | 5 | 23 |
| 2017 8 | 18 | 4 | 22 |
| 2017 7 | 22 | 10 | 32 |
| 2017 6 | 18 | 20 | 38 |
| 2017 5 | 22 | 17 | 39 |
| 2017 4 | 19 | 6 | 25 |
| 2017 3 | 22 | 18 | 40 |
| 2017 2 | 21 | 8 | 29 |
| 2016 1 | 21 | 8 | 29 |
| 2016 12 | 36 | 10 | 46 |
| 2016 11 | 39 | 11 | 50 |
| 2016 10 | 53 | 14 | 67 |
| 2016 9 | 49 | 15 | 64 |
| 2016 8 | 32 | 7 | 39 |
| 2016 7 | 21 | 8 | 29 |
| 2016 6 | 50 | 19 | 69 |
| 2016 5 | 40 | 16 | 56 |
| 2016 4 | 38 | 11 | 49 |
| 2016 3 | 29 | 20 | 49 |
| 2016 2 | 28 | 18 | 46 |
| 2015 1 | 28 | 23 | 51 |
| 2015 12 | 31 | 15 | 46 |
| 2015 11 | 47 | 21 | 68 |
| 2015 10 | 50 | 16 | 66 |
| 2015 9 | 44 | 12 | 56 |
| 2015 8 | 45 | 9 | 54 |
| 2015 7 | 38 | 5 | 43 |
| 2015 6 | 20 | 7 | 27 |
| 2015 5 | 35 | 9 | 44 |
| 2015 4 | 34 | 5 | 39 |
| 2015 3 | 33 | 8 | 41 |
| 2015 2 | 42 | 5 | 47 |
| 2015 1 | 54 | 7 | 61 |
| 2014 12 | 79 | 7 | 86 |
| 2014 11 | 66 | 5 | 71 |
| 2014 10 | 62 | 8 | 70 |
| 2014 9 | 72 | 4 | 76 |
| 2014 8 | 57 | 7 | 64 |
| 2014 7 | 84 | 5 | 89 |
| 2014 6 | 70 | 5 | 75 |
| 2014 5 | 57 | 1 | 58 |
| 2014 4 | 45 | 5 | 50 |
| 2014 3 | 56 | 3 | 59 |
| 2014 2 | 47 | 3 | 50 |
| 2014 1 | 56 | 2 | 58 |
| 2013 12 | 74 | 5 | 79 |
| 2013 11 | 84 | 2 | 86 |
| 2013 10 | 76 | 5 | 81 |
| 2013 9 | 57 | 6 | 63 |
| 2013 8 | 60 | 8 | 68 |
| 2013 7 | 48 | 3 | 51 |
| 2013 6 | 15 | 0 | 15 |
| 2013 5 | 8 | 0 | 8 |
| 2013 4 | 2 | 0 | 2 |
| 2013 3 | 1 | 0 | 1 |
| 2013 1 | 1 | 0 | 1 |
| 2012 11 | 2 | 0 | 2 |
| 2012 9 | 375 | 0 | 375 |
Mostrar todo
